Imiquimod is a strong inhibitor of tumor cell‐induced angiogenesis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (47)
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 • 7,717 citations
Cloning of a new cytokine that induces IFN-γ production by T cells
1995 • 2,584 citations
Inhibition of Angiogenesis In Vivo by Interleukin 12
1995 • 734 citations
Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein.
1996 • 635 citations
Interferon‐γ‐inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin‐12 for interferon‐γ production
1996 • 606 citations
Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
1987 • 491 citations
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
1996 • 480 citations
IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
1996 • 425 citations
Angiogenesis and angiogenesis inhibition: An overview
1997 • 419 citations
Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.
1998 • 419 citations
Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug
1999 • 412 citations
Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
1999 • 375 citations
Treatment of genital warts with an immune-response modifier (imiquimod)
1998 • 308 citations
Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.
2000 • 295 citations
Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction.
1975 • 285 citations
Imiquimod 5% cream in the treatment of Bowen's disease
2001 • 269 citations
Cytokine induction by the immunomodulators imiquimod and S-27609
1995 • 268 citations
A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod
1998 • 255 citations
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
2000 • 199 citations
Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion
2002 • 192 citations
Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine.
1992 • 174 citations
Biological implications of macrophage infiltration in human tumor angiogenesis
1999 • 160 citations
Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection
1988 • 158 citations
In vivo antitumor effects of murine interferon- γ -inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites
1997 • 154 citations
Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases
2001 • 138 citations
Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial
2002 • 130 citations
Synergistic effect of retinoids and interferon α on tumor‐induced angiogenesis: Anti‐angiogenic effect on HPV‐harboring tumor‐cell lines
1994 • 123 citations
Imiquimod 5% cream (Aldara™)
1998 • 115 citations
Both E6 and E7 Oncoproteins of Human Papillomavirus 16 Inhibit IL-18-Induced IFN-γ Production in Human Peripheral Blood Mononuclear and NK Cells
2001 • 111 citations
Molecular foundations of cancer: New targets for intervention
1995 • 98 citations
Down modulation of IL‐18 expression by human papillomavirus type 16 E6 oncogene via binding to IL‐18
2001 • 96 citations
Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections
1989 • 80 citations
Imiquimod: A cytokine inducer
2002 • 74 citations
Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis
2002 • 72 citations
Retinoids, Interferon α, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RARα mediates the antiangiogenic effect of retinoids
1995 • 71 citations
Bowen's Disease (Squamous Cell Carcinoma In Situ) in Immunosuppressed Patients Treated with Imiquimod 5% Cream and a COX Inhibitor, Sulindac: Potential Applications for This Combination of Immunotherapy
2001 • 69 citations
Interleukin-12 Inhibits Angiogenesis Induced by Human Tumor Cell Lines In Vivo
1996 • 67 citations
Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-alpha.
1992 • 63 citations
Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases.
2000 • 57 citations
Imiquimod: a potential role in dermatology?
2002 • 46 citations
Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry
2002 • 43 citations
Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report
2002 • 39 citations
Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors
2002 • 33 citations
Expression of the human papillomavirus type 16 genome in SK-v cells, a line derived from a vulvar intraepithelial neoplasia
1990 • 25 citations
Imiquimod
1999 • 19 citations
Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms
2002 • 18 citations
[Recurrent Bowen's disease of the nail: treatment by topical imiquimod (Aldara)].
2003 • 18 citations